eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiothoracic Surgery

Coarctation of the Aorta and Interrupted Aortic Arch: Surgical Perspective

Author: Theodore C Koutlas, MD, Assistant Professor, Department of Surgery, Division of Cardiothoracic Surgery, Pitt County Memorial Hospital
Coauthor(s): David M Maziarz, MD, Fellow, Department of Surgery, Wake Forest University Baptist Medical Center; Clifton C Reade, MD, Fellow, Department of Cardiothoracic Surgery, University of Pennsylvania
Contributor Information and Disclosures

Updated: May 4, 2006

Introduction

Coarctation is a term derived from the Latin coarctation, meaning a drawing or pressing together. More precisely, coarctation refers to a narrowing of the lumen of a vessel producing an obstruction to flow. A localized segment of narrowing is called a coarctation, whereas a diffuse segment of narrowing is known as tubular hypoplasia.

Coarctation was once described as infantile and adult; however, these descriptions were not accurate because both types can be observed in either age group. As our understanding of the pathophysiology of coarctation evolved, the terms preductal and postductal were often used to categorize coarctation in relation to the ductus arteriosus. Although this anatomic description remains true, the exact location usually does not change the presentation; this knowledge has, led to the unified description of most neonatal coarctation as juxtaductal.

History of the Procedure

Meckel originally noted coarctation on autopsy in 1750, and Morgagni again noted it in 1760. Forty-four years after Paris provided the first accurate description of coarctation of the aorta in 1791, Legrand made the first diagnosis in a living patient in 1835. Bonnet was the first to categorize coarctation into infantile and adult forms, which were later revised to preductal and postductal forms.

Blalock and Park proposed the first surgical repair in 1944, describing a bypass from the left subclavian artery to the aorta to circumvent the area of narrowing. Crafoord and Nylin performed the first resection with end-to-end reanastomosis in 1945, whereas Gross used homografts to replace the narrowed segments of aorta. In 1966, Waldhausen and Nahrwold performed the first subclavian-flap aortoplasty. More recently, advanced interventional cardiology techniques have led to an interest in percutaneous transluminal aortoplasty for both native coarctation and recoarctation.

Problem

Coarctation

Coarctation is defined as a narrowing of the lumen of the aorta that obstructs flow. Variations of coarctation depend on the length of the involved segment. Typically located at the insertion of the ductus or ligamentum arteriosum, a localized coarctation may occur at any point along the length of the aorta. Coarctation rarely occurs at multiple sites, a phenomenon sometimes observed in Turner syndrome. Diffuse long-segment coarctation, also known as tubular hypoplasia, is typically found at the aortic isthmus (ie, the segment between the left subclavian artery and the insertion of the ductus). With extreme coarctation, the entire transverse arch may be hypoplastic.

Pseudocoarctation

Souders first described pseudocoarctation in 1951. Often discovered on simple chest radiography, the aorta has an abnormal contour. Aortography shows a tortuous, kinked aorta with no gradient. Kinking or buckling of the aorta changes the healthy conformation of the aorta but does not obstruct flow. Once thought benign, aneurysmal dilation can occur distal to the affected area, leading to the specter of rupture of the aorta. Current therapy requires close follow-up care. Aggressively pursue surgical repair after the aorta begins to demonstrate progressive dilation.

Complete interruption of the aortic arch

Complete interruption of the aorta, or interrupted aortic arch (IAA), is a fairly rare condition. First described in 1778 by Steidele, IAA accounts for less than 1.5% of all instances of congenital heart disease. Complete interruption of the aorta is usually associated with other anomalies, including DiGeorge syndrome (29% incidence) (Schreiber, 1997). In 1955, Samson performed the first known surgical correction of IAA. Sirak performed the first repair in a neonate in 1968.

Defined as a complete absence of a segment of the aortic arch, the description of IAA is based on the absent segment. In 1959, Celoria and Patton developed the following classification of IAA; Schreiber et al provided the percentages in 1997:

  • Type A (13%): Interruption occurs between the left subclavian artery and the descending aorta.
  • Type B (84%): Interruption occurs between the left subclavian artery and the left common carotid artery.
  • Type C (3%): The absent segment occurs between the left common carotid artery and the innominate artery.
  • Subtypes A1, B1, and C1: All describe an anomalous origin of the right subclavian artery from the distal aorta.

Although the cause is unknown, IAA is associated with defects that decrease ascending aortic flow and increase ductal flow. As with coarctation, abnormal fetal blood-flow patterns are theorized to substantially contribute to the etiology of IAA.

Previously uniformly fatal, the development of prostaglandin E1 (PGE1) therapy to maintain ductal patency has greatly improved surgical results by allowing time to optimize the patient's hemodynamic state before surgery. The prognosis of patients with IAA is poor if the condition is uncorrected. The mean age at death is 4-10 days, with 90% dying within the first year of life. After repair, the 10-year survival rate is approximately 47% (Sell, 1988).

Whether a staged repair or a single operation should be used to repair IAA remains controversial. Median sternotomy is still preferred if correction of associated anomalies is to occur concomitantly. Methods of surgical correction are similar to those of coarctation repair and include end-to-end anastomosis of the remaining segments with or without patch augmentation, end-to-side anastomosis of the arch vessel with either the proximal or distal segment, or use of an interposition graft to take the place of the missing segment.

Mortality

Most data demonstrate that mortality rates decrease and outcomes improve with increasing experience. In their series, Schreiber et al demonstrated that early mortality rates decreased from 42% in 1975-1985 to only 17% in 1985-1995, which was a result of improved surgical techniques and advances in the preoperative and postoperative treatment of neonates. Immediate surgical intervention remains the only therapy. IAA is a difficult surgical problem, though the most recent results have been encouraging, with increased survival and decreased morbidity rates.

Frequency

Observed in 1 in 3000 to 1 in 4000 autopsies, coarctation accounts for approximately 5-10% of cases of congenital heart disease. Isolated coarctation is more common in males than in females, whereas the incidence of complex lesions is equal in males and females. The birth prevalence of coarctation for patients in 1980-1994 was 0.32 case per 1000 live births (Grech, 1999).

Etiology

Although the cause of coarctation remains controversial, 2 major theories are supported by the current literature.

Muscular theory

The muscular theory suggests that extension of tissue from the ductus arteriosus (a muscular artery) extends into the aorta (an elastic artery) during development. When the ductus contracts and fibroses at birth, it leads to a narrowing of the aortic lumen.

Theory of abnormal fetal blood-flow patterns

The second theory is related to abnormal fetal blood-flow patterns. During fetal development, the aortic isthmus is a watershed area, as the ascending aorta receives blood from the heart, sending it to the head, while the descending aorta receives ductal blood to send to the rest of the body. As a result, the initial diameter of the isthmus is small, and if the proper molecular cues are not present, it may not grow sufficiently. The incidence of coarctation is increased in disorders in which an obstruction of the left ventricular outflow tract reduces ascending aortic flow. In converse, the incidence is decreased in disorders in which decreased ductal flow is present, such as tetralogy of Fallot.

Combination of theories

Although both theories provide ample evidence, a combination probably best encompasses the likely etiology (Van Son, 1993).

Common associated anomalies of coarctation of the aorta include bicuspid aortic valve, ventricular septal defect (VSD), patent ductus arteriosus, and various mitral-valve disorders. Congenital aortic stenosis, aortic atresia, and hypoplastic left-heart syndrome are less common. On occasion, coarctation to the aorta is observed in transposition of the great vessels, particularly when the right ventricular outflow tract is obstructed. Data suggest that more than 70% of VSDs that occur with coarctation may close spontaneously (Moene, 1987; Park, 1992). Coarctation is observed in as many as 50% of patients with the Taussig-Bing anomaly (Parr, 1983; Sadow, 1985). A genetic or familial basis may be involved because 15-36% of children with Turner syndrome may have coarctation.

Pathophysiology

The pathophysiology of untreated coarctation revolves around the associated hypertension. A 3-pronged hypertensive response occurs in the presence of coarctation. Blood pressure is mechanically affected at all levels and at the level of the kidneys, and recent data suggest that hypertension evolves from an endothelial process as well.

The natural history of coarctation depends on the age of the individual at presentation and on the associated anomalies. Symptomatic infants have a high mortality rate, and those who survival to adulthood still have greatly decreased life expectancy, even with surgical correction. The data have changed somewhat over the years with the introduction of antibiotics and improved neonatal care; however, untreated coarctation still results in a grave prognosis.

In 1928, Abbott reviewed 200 cases with coarctation in patients older than 2 years and found that 34% died by the time they were aged 40 years, with an average age at death of 42 years. At that time, the 3 major causes of death were spontaneous rupture of the aorta, bacterial endocarditis, and cerebral hemorrhage.

Neonates usually present with left ventricular failure as a result of severe and acute afterload, which is further exacerbated by acidosis. This acidosis results from diminished peripheral flow secondary to the coarct itself, in addition to the failing left ventricle.

Twenty years later, in 1947, Reifenstein reviewed 104 cases and found little change, with an average age at death of 35 years. The 2 leading causes of death were unchanged. By 1970, the results had improved somewhat; however, the mortality rate was still 75% by the time a person with coarctation was aged 46 years (Campbell, 1970). In persons with untreated coarctation, the coronary arteries have intimal degeneration, medial thickening, and increased mineralization, all of which are secondary to the hypertension associated with untreated disease.

Presentation

The clinical presentation of patients with coarctation depends on their age at presentation and on the presence and severity of any associated anomalies. The 2 clinically significant variants, preductal and postductal coarctation, can manifest in different ways.

Preductal coarctation

Preductal coarctation is associated with an increased incidence of cardiac defects, and the patient may present with congestive heart failure (CHF) if a VSD is present. A preductal defect does not change normal fetal blood-flow patterns. As a result, no collaterals form in utero. If blood flows through the patent ductus arteriosus, pulses are often palpable in the lower extremities. Symptoms develop as the ductus closes, leading to a clinically significant obstruction.

On clinical examination, the infant often is irritable and disinterested in feeding. Tachycardia is often present. Few findings may be apparent on physical examination in a healthy-appearing infant. However, in the uncompensated patient, differential cyanosis may be observed between the upper body and the lower body. A systolic murmur may be present over the left precordium or between the scapulae on the patient's back. An infant who is compensating (ie, one with a left-to-right shunt through a patent foramen ovale) should have a substantial systolic blood-pressure gradient between the arms and the legs.

Physical findings in a neonate who is decompensating and critically ill may differ substantially. The blood-pressure gradient is often absent secondary to diminished cardiac output. Hypotension, oliguria, and severe metabolic acidosis are concurrent with severe coarctation, as blood flow to the kidneys and all distal structures is drastically impaired. In severe obstruction or in IAA, diagnosis by physical examination can be obscured as long as the ductus remains patent because the pulmonary artery pulse is palpated in the femoral arteries.

Paraductal and postductal anomalies

Paraductal and postductal anomalies are often isolated defects, and the incidence of associated anomalies is low. Later in life, patients may present with headache, epistaxis, or visual disturbances. Exertional dyspnea and stroke are other presenting symptoms (Shearer, 1970).

Coarctation can be clinically diagnosed depending on the available evidence, as described above. To summarize, hypertension or a systolic blood-pressure gradient between the arms and legs may be observed. Checking the patient's blood pressure in both arms is important because an anomalous origin of the right subclavian distal to the coarcted segment may be present. A systolic murmur over the left precordium or between the scapulae may be heard, and the femoral pulses may be absent or diminished with a delayed upstroke. In children older than 5 years, look for the signs of collateral circulation, ie, enlarged and palpable collateral vessels, audible bruits, and dilatation of the intercostals (rib notching).

Indications

The presence of coarctation alone is usually indication for surgery. Timing of the operation and the method of repair are decisions to be made. Symptomatic infants often require urgent surgery. However, the patient's condition must be stabilized with medical therapy before the coarctations is repaired. Neonates often present with profound acidosis and respiratory distress. An infusion of PGE1 may be administered within a month of birth, and it often opens a closed ductus.

Relevant Anatomy

The most relevant anatomy for understanding coarctation of the aorta is the aortic arch, the great vessels, and the insertion of the ductus. Because coarctation and IAA can occur anywhere along the arch, being able to recognize the origins of the great vessels, especially on aortography, is important. The ductus arteriosus is a remnant of the sixth left aortic arch; it connects the pulmonary trunk with the aorta in utero and attaches to the lower concave surface of the aortic arch directly opposite the left common carotid and left subclavian arteries. The left recurrent laryngeal nerve hooks around the lower border of this structure and can easily be damaged if care is not taken to avoid it.

Contraindications

Generally considered a life-saving procedure, repair of coarctation has few absolute contraindications. Coexisting illnesses or anomalies in an infant (eg, necrotizing enterocolitis) make take initial precedence in treatment. Sepsis is likely the greatest relative contraindication to surgery. This condition is related to the overall inflammatory response and to edema formation observed with the septic immune response. Dissection into the periaortic space is made more difficult that is otherwise would be, and the crucial tension-free anastomoses are considerable more difficult to construct than they are in other situations.

More on Coarctation of the Aorta and Interrupted Aortic Arch: Surgical Perspective

Overview: Coarctation of the Aorta and Interrupted Aortic Arch: Surgical Perspective
Workup: Coarctation of the Aorta and Interrupted Aortic Arch: Surgical Perspective
Treatment: Coarctation of the Aorta and Interrupted Aortic Arch: Surgical Perspective
Follow-up: Coarctation of the Aorta and Interrupted Aortic Arch: Surgical Perspective
References

References

  1. Abbott ME. Coarctation of the aorta of the adult type. Am. Heart J. 1928;3:574.

  2. Aeba R, Katogi T, Ueda T, et al. Complications following reparative surgery for aortic coarctation or interrupted aortic arch. Surg Today. 1998;28(9):889-94. [Medline].

  3. Aebert H, Laas J, Bednarski P, et al. High incidence of aneurysm formation following patch plasty repair of coarctation. Eur J Cardiothorac Surg. 1993;7(4):200-4; discussion 205. [Medline].

  4. Allen BS, Halldorsson AO, Barth MJ, Ilbawi MN. Modification of the subclavian patch aortoplasty for repair of aortic coarctation in neonates and infants. Ann Thorac Surg. Mar 2000;69(3):877-80; discussion 881. [Medline].

  5. Backer CL, Mavroudis C, Zias EA, et al. Repair of coarctation with resection and extended end-to-end anastomosis. Ann Thorac Surg. Oct 1998;66(4):1365-70; discussion 1370-1. [Medline].

  6. Bogers AJ, Contant CM, Hokken RB, Cromme-Dijkhuis AH. Repair of aortic arch interruption by direct anastomosis. Eur J Cardiothorac Surg. Jan 1997;11(1):100-4. [Medline].

  7. Campbell M. Natural history of coarctation of the aorta. Br Heart J. Sep 1970;32(5):633-40. [Medline].

  8. Celoria GC, Patton RB. Congenital absence of the aortic arch. Am. Heart J. 1959;58:408.

  9. Cowley CG, Orsmond GS, Feola P, et al. Long-term, randomized comparison of balloon angioplasty and surgery for native coarctation of the aorta in childhood. Circulation. Jun 28 2005;111(25):3453-6. [Medline].

  10. Cunningham JN Jr, Laschinger JC, Spencer FC. Monitoring of somatosensory evoked potentials during surgical procedures on the thoracoabdominal aorta. IV. Clinical observations and results. J Thorac Cardiovasc Surg. Aug 1987;94(2):275-85. [Medline].

  11. DeLeon MM, DeLeon SY, Quinones JA, et al. Management of arch hypoplasia after successful coarctation repair. Ann Thorac Surg. Apr 1997;63(4):975-80. [Medline].

  12. Fiore AC, Fischer LK, Schwartz T, et al. Comparison of angioplasty and surgery for neonatal aortic coarctation. Ann Thorac Surg. Nov 2005;80(5):1659-64; discussion 1664-5. [Medline].

  13. Grech V. Diagnostic and surgical trends, and epidemiology of coarctation of the aorta in a population-based study. Int J Cardiol. Feb 28 1999;68(2):197-202. [Medline].

  14. Hirooka K, Fraser CD Jr. One-stage neonatal repair of complex aortic arch obstruction or interruption. Recent experience at Texas Children''s Hospital. Tex Heart Inst J. 1997;24(4):317-21. [Medline].

  15. Jahangiri M, Shinebourne EA, Zurakowski D, et al. Subclavian flap angioplasty: does the arch look after itself?. J Thorac Cardiovasc Surg. Aug 2000;120(2):224-9. [Medline].

  16. Jenkins NP, Ward C. Coarctation of the aorta: natural history and outcome after surgical treatment. QJM. Jul 1999;92(7):365-71. [Medline].

  17. Jimenez M, Daret D, Choussat A, Bonnet J. Immunohistological and ultrastructural analysis of the intimal thickening in coarctation of human aorta. Cardiovasc Res. Mar 1999;41(3):737-45. [Medline].

  18. Kawauchi M, Tada Y, Asano K, Sudo K. Angiographic demonstration of mesenteric arterial changes in postcoarctectomy syndrome. Surgery. Sep 1985;98(3):602-4. [Medline].

  19. Mainwaring RD, Lamberti JJ. Mid- to long-term results of the two-stage approach for type B interrupted aortic arch and ventricular septal defect. Ann Thorac Surg. Dec 1997;64(6):1782-5; discussion 1785-6. [Medline].

  20. Marshall AC, Perry SB, Keane JF, Lock JE. Early results and medium-term follow-up of stent implantation for mild residual or recurrent aortic coarctation. Am Heart J. Jun 2000;139(6):1054-60. [Medline].

  21. Moene RJ, Gittenberger-de Groot AC, Oppenheimer-Dekker A, Bartelings MM. Anatomic characteristics of ventricular septal defect associated with coarctation of the aorta. Am J Cardiol. Apr 15 1987;59(9):952-5. [Medline].

  22. O''Connor AR, Moody AR, Ludman CN. Images in cardiology. Aortic coarctation diagnosed by magnetic resonance angiography. Heart. Jun 1999;81(6):671. [Medline][Full Text].

  23. Ovaert C, McCrindle BW, Nykanen D, et al. Balloon angioplasty of native coarctation: clinical outcomes and predictors of success. J Am Coll Cardiol. Mar 15 2000;35(4):988-96. [Medline].

  24. Park JK, Dell RB, Ellis K, Gersony WM. Surgical management of the infant with coarctation of the aorta and ventricular septal defect. J Am Coll Cardiol. Jul 1992;20(1):176-80. [Medline].

  25. Parr GV, Waldhausen JA, Bharati S, et al. Coarctation in Taussig-Bing malformation of the heart. Surgical significance. J Thorac Cardiovasc Surg. Aug 1983;86(2):280-7. [Medline].

  26. Reifenstein GH, Levine SA, Gross RE. Coarctation of the aorta: a review of 104 autopsied cases of the "adult type" 2 years of age or older. Am Heart J. 1947;33:146.

  27. Rothman A. Coarctation of the aorta: an update. Curr Probl Pediatr. Feb 1998;28(2):33-60. [Medline].

  28. Rudolph AM, Heymann MA, Spitznas U. Hemodynamic considerations in the development of narrowing of the aorta. Am J Cardiol. Oct 1972;30(5):514-25. [Medline].

  29. Saba SE, Nimri M, Shamaileh Q, et al. Balloon coarctation angioplasty: follow-up of 103 patients. J Invasive Cardiol. Aug 2000;12(8):402-6. [Medline].

  30. Sadow SH, Synhorst DP, Pappas G. Taussig-Bing anomaly and coarctation of the aorta in infancy: surgical options. Pediatr Cardiol. 1985;6(2):83-9. [Medline].

  31. Sakopoulos AG, Hahn TL, Turrentine M, Brown JW. Recurrent aortic coarctation: is surgical repair still the gold standard?. J Thorac Cardiovasc Surg. Oct 1998;116(4):560-5. [Medline].

  32. Schreiber C, Mazzitelli D, Haehnel JC, et al. The interrupted aortic arch: an overview after 20 years of surgical treatment. Eur J Cardiothorac Surg. Sep 1997;12(3):466-9; discussion 469-70. [Medline].

  33. Sciolaro C, Copeland J, Cork R, et al. Long-term follow-up comparing subclavian flap angioplasty to resection with modified oblique end-to-end anastomosis. J Thorac Cardiovasc Surg. Jan 1991;101(1):1-13. [Medline].

  34. Seirafi PA, Warner KG, Geggel RL, et al. Repair of coarctation of the aorta during infancy minimizes the risk of late hypertension. Ann Thorac Surg. Oct 1998;66(4):1378-82. [Medline].

  35. Shearer WT, Rutman JY, Weinberg WA, Goldring D. Coarctation of the aorta and cerebrovascular accident: a proposal for early corrective surgery. J Pediatr. Dec 1970;77(6):1004-9. [Medline].

  36. Thanopoulos BD, Hadjinikolaou L, Konstadopoulou GN, et al. Stent treatment for coarctation of the aorta: intermediate term follow up and technical considerations. Heart. Jul 2000;84(1):65-70. [Medline].

  37. Tlaskal T, Hucin B, Hruda J, et al. Results of primary and two-stage repair of interrupted aortic arch. Eur J Cardiothorac Surg. Sep 1998;14(3):235-42. [Medline].

  38. Ungerleider RM, Ebert PA. Indications and techniques for midline approach to aortic coarctation in infants and children. Ann Thorac Surg. Nov 1987;44(5):517-22. [Medline].

  39. Van Son JA, Mohr FW, Hess H, et al. Early repair of coarctation of the aorta. Ann Thorac Cardiovasc Surg. Aug 1999;5(4):237-44. [Medline].

  40. Vitullo DA, DeLeon SY, Graham LC, et al. Extended end-to-end repair and enlargement of the entire arch in complex coarctation. Ann Thorac Surg. Feb 1999;67(2):528-31. [Medline].

  41. Wong CH, Watson B, Smith J. The use of left heart bypass in adult and recurrent coarctation repair. Eur J Cardiothorac Surg. Dec 2001;20(6):1199-201. [Medline].

  42. Wood MK. Acyanotic cardiac lesions with normal pulmonary blood flow. Neonatal Netw. Apr 1998;17(3):5-11. [Medline].

Further Reading

Keywords

coarctation of the aorta and interrupted aortic arch, CoA, coarctation tubular hypoplasia, IAA, interrupted aortic arch, infantile coarctation, adult coarctation, preductal coarctation, postductal coarctation, juxtaductal coarctation, recoarctation, tubular hypoplasia, pseudocoarctation, DiGeorge syndrome, DiGeorge's syndrome, ventricular septal defect, VSD, Turner syndrome, Turner's syndrome

Contributor Information and Disclosures

Author

Theodore C Koutlas, MD, Assistant Professor, Department of Surgery, Division of Cardiothoracic Surgery, Pitt County Memorial Hospital
Theodore C Koutlas, MD is a member of the following medical societies: American College of Surgeons, Society of Thoracic Surgeons, and Southern Thoracic Surgical Association
Disclosure: Nothing to disclose.

Coauthor(s)

David M Maziarz, MD, Fellow, Department of Surgery, Wake Forest University Baptist Medical Center
David M Maziarz, MD is a member of the following medical societies: American College of Surgeons
Disclosure: Nothing to disclose.

Clifton C Reade, MD, Fellow, Department of Cardiothoracic Surgery, University of Pennsylvania
Clifton C Reade, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, Society of Thoracic Surgeons, and Southeastern Surgical Congress
Disclosure: Nothing to disclose.

Medical Editor

Daniel S Schwartz, MD, FACS, Clinical Assistant Professor of Cardiothoracic Surgery, New York University School of Medicine; Consulting Staff, Department of Surgery, Division of Thoracic Surgery, North Shore University Hospital/Long Island Jewish Medical Center
Daniel S Schwartz, MD, FACS is a member of the following medical societies: American Association for the Advancement of Science, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, American Diabetes Association, American Heart Association, American Medical Association, Association for Academic Surgery, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Mary C Mancini, MD, PhD, Professor, Department of Surgery, Louisiana State University Health Sciences Center
Mary C Mancini, MD, PhD is a member of the following medical societies: American Heart Association, American Medical Association, American Thoracic Society, Association for Academic Surgery, Association for Surgical Education, International College of Surgeons, International Society for Heart and Lung Transplantation, New York Academy of Sciences, Phi Beta Kappa, and Southern Thoracic Surgical Association
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting; Pfizer Honoraria Consulting

Chief Editor

John Kupferschmid, MD, Director of Congenital Heart Surgery, Department of Surgery, Methodist Children's Hospital at San Antonio
John Kupferschmid, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, Society of Thoracic Surgeons, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.